Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia
Gram
Gram-Negative Bacteria
DOI:
10.1128/spectrum.01714-23
Publication Date:
2024-04-17T13:02:26Z
AUTHORS (21)
ABSTRACT
ABSTRACT In this study, the genetic differences and clinical impact of carbapenemase-encoding genes among community healthcare-acquired infections were assessed. This retrospective, multicenter cohort study was conducted in Colombia included patients infected with carbapenem-resistant Gram-negative rods between 2017 2021. Carbapenem resistance identified by Vitek, whole-genome sequencing (WGS) to classify alleles sequence types (STs). Descriptive statistics used determine association any pathogen or gene outcomes. A total 248 included, which only 0.8% (2/248) had community-acquired infections. Regarding bacteria, most prevalent pathogens Pseudomonas aeruginosa Klebsiella pneumoniae . WGS analysis, 228 isolates passed all quality criteria analyzed. The principal bla KPC, specifically KPC-2 [38.6% (88/228)] KPC-3 [36.4% (83/228)]. These frequently detected co-concurrence VIM-2 NDM-1 Notably, allele [50.0% (1/2)]. reference STs, 78 identified, ST111 mainly related blaKPC-3. ST512, ST258, ST14, ST1082 exclusively associated KPC-3. Finally, no particular worse carbapenemase-producing KPC-3, both co-occurrence diverse STs healthcare environment. Patients several systemic complications poor outcomes that not a gene. IMPORTANCE Antimicrobial is pandemic worldwide public health problem, especially carbapenem low- middle-income countries. Limited data regarding molecular characteristics these bacteria are available. Thus, our described community- identified. We also found distinct types, two novel , could represent challenges treating Our shows low countries, such as Colombia, burden concern for health, regardless allele, studies assessing local epidemiology, prevention strategies (including trials), underpinning mechanisms urgently needed,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....